National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C07AB12	NIVOL	G	Nebivolol HCl - 5mg	5mg	Tablet	590,011 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 40mg	40mg	Injectable powder for solution	188,138 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 125mg	125mg	Injectable powder for solution	469,001 L.L
C07BB12	NIVOL PLUS	G	Nebivolol HCl - 5mg, Hydrochlorothiazide - 12.5mg	5mg	Tablet	609,209 L.L
G02CB03	NOSTIFIX	G	Cabergoline - 0.5mg	0.5mg	Tablet	976,973 L.L
G02CB03	NOSTIFIX	G	Cabergoline - 0.5mg	0.5mg	Tablet	248,611 L.L
B05XA31	NUTRYELT	G	Zinc (gluconate) - 10000mcg/10ml, Copper (gluconate) - 300mcg/10ml, Manganese (gluconate) - 55mcg/10ml, Sodium fluoride - 950mcg/10ml, Iodine potassium iodide - 130mcg/10ml, Selenium (sodium salt) - 70mcg/10ml, Molybdenum (Sodium molybdate) - 20mcg/10ml, Chrome (chlorure) - 10mcg/10ml, Ferrous (gluconate) - 1000mcg/10ml		Injectable concentrate for solution	3,483,240 L.L
A03FA03	NAUZEX	G	Domperidone - 10mg	10mg	Tablet	258,530 L.L
A03FA03	NOVADOM	G	Domperidone - 10mg	10mg	Tablet	278,175 L.L
S01AE02	NAFLOX	G	Norfloxacin - 3mg/ml	3mg/ml	Drops	370,901 L.L
G03AA12	NAJAT	G	Drospirenone - 3mg, Ethinylestradiol - 0.03mg		Tablet, coated	417,935 L.L
C08CA01	NIPIDOL	G	Amlodipine - 5mg	5mg	Tablet	255,330 L.L
A04AA01	NAUSETRON	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, scored	1,023,880 L.L
A04AA01	NOZENTRIX	G	Ondansetron - 8mg	8mg	Tablet, film coated	1,151,865 L.L
C08CA01	NIPIDOL	G	Amlodipine - 10mg	10mg	Tablet	377,620 L.L
C08CA04	NICARDIPINE ARROW	G	Nicardipine chlorhydrate - 10mg/10ml	10mg/10ml	Injectable solution	2,590,928 L.L
C08CA04	NICARDIPINE MEDIS	G	Nicardipine chlorhydrate - 10mg/10ml	10mg/10ml	Injectable solution	1,295,464 L.L
C08CA05	NIFELAT R	G	Nifedipine - 20mg	20mg	Tablet, sustained release	388,370 L.L
C08CA05	NIFELAT 30 LA	G	Nifedipine - 30mg	30mg	Tablet, prolonged release	1,007,882 L.L
C08CA05	NIFELAT 60 LA	G	Nifedipine - 60mg	60mg	Tablet, prolonged release	1,290,089 L.L
C08CA05	NIFE-PAR	G	Nifedipine - 5mg/ml	5mg/ml	Solution	38,120,008 L.L
R03BB04	NEUMOTROPIO	G	Tiotropium bromide - 10mcg	10mcg	Capsule, inhalation	3,115,844 L.L
B01AC04	NORMIGORE	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet, film coated	1,184,117 L.L
C01CA03	NORADRENALINE NOREPINEPHRINE (tartrate) Aguettant	G	Norepinephrine tartrate - 2mg/ml	2mg/ml	Injectable solution	1,896,162 L.L
C01CA03	NORADRENALINE NOREPINEPHRINE (tartrate) Aguettant	G	Norepinephrine tartrate - 2mg/ml	2mg/ml	Injectable solution	1,896,162 L.L
C01CA03	NORADRENALINE RENAUDIN	G	Norepinephrine tartrate - 8mg/4ml	0.2%	Injectable solution	2,000,981 L.L
A04AA01	NOZAMET	G	Ondansetron - 8mg	8mg	Film, orodispersible	6,075,448 L.L
C01CA03	NORADRENALINE HIKMA	G	Noradrenaline bitartrate - 4mg/4ml	4mg/4ml	Injectable solution	1,279,338 L.L
B01AC06	NU-SEALS	G	Acetylsalicylic acid - 75mg	75mg	Tablet, enteric coated	403,153 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	958,608 L.L